Pharmaceutical

Cristália signs licensing deal for Formosa’s APP13007

Cristália has signed an agreement to license exclusive rights to market Formosa Pharmaceuticals’ APP13007 in Brazil.

Jan 29, 2024 - 18:00
Cristália signs licensing deal for Formosa’s APP13007
Cristália has signed an agreement to license exclusive rights to market Formosa Pharmaceuticals’ APP13007 in Brazil.
Read the original article

Tags:

Previous Article

Cell and gene therapies – top pharmaceutical industry trend to watch for 2024

Next Article

FDA grants priority review for Daiichi Sankyo-AstraZeneca’s Enhertu

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: If AI invents a new medicine, who gets the patent?

STAT+: If AI invents a new medicine, who gets the patent?

Jun 8, 2023

A chatbot that’s cautious about GPT, AI pronouncements, and a VC looks to Israel

A chatbot that’s cautious about GPT, AI pronouncements,...

Jun 16, 2023

STAT+: Biogen board and C-suite are in step as they eye M&A opportunities, new CEO says

STAT+: Biogen board and C-suite are in step as they eye...

Jun 6, 2023